Literature DB >> 9415395

Early signaling events triggered by peroxovanadium [bpV(phen)] are insulin receptor kinase (IRK)-dependent: specificity of inhibition of IRK-associated protein tyrosine phosphatase(s) by bpV(phen).

C J Band1, B I Posner, V Dumas, J O Contreres.   

Abstract

Peroxovanadiums (pVs) are potent protein tyrosine phosphatase (PTP) inhibitors with insulin-mimetic properties in vivo and in vitro. We have established the existence of an insulin receptor kinase (IRK)-associated PTP whose inhibition by pVs correlates closely with IRK tyrosine phosphorylation, activation, and downstream signaling. pVs have also been shown to activate various tyrosine kinases (TKs) that could participate in activation of the insulin-signaling pathway. In the present study we have sought to determine whether pV-induced IRK tyrosine phosphorylation requires the intrinsic kinase activity of the IRK, and whether IRK activation is necessary to realize the early steps in the insulin-signaling cascade. To address this we evaluated the effect of a pure pV compound, bis peroxovanadium 1,10-phenanthroline [bpV(phen)], in HTC rat hepatoma cells overexpressing normal (HTC-IR) or kinase-deficient (HTC-M1030) mutant IRKs. We showed that at a dose of 0.1 mM, but not 1 mM, bpV(phen) induced IRK-dependent events. Thus, 0.1 mM bpV(phen) increased tyrosine phosphorylation and IRK activity in HTC-IR but not HTC-M1030 cells. Tyrosine phosphorylation of insulin signal-transducing molecules was promoted in HTC-IR but not HTC-M1030 cells by bpV(phen). The association of p185 and p60 with the src homology-2 (SH2) domains of Syp and the p85-regulatory subunit of phosphatidylinositol 3'-kinase was induced by bpV(phen) in HTC-IR, but not in HTC-M1030 cells, as was insulin receptor substrate-1-associated phosphatidylinositol 3'-kinase activity. Thus autophosphorylation and activation of the IRK by bpV(phen) is effected by the IRK itself, and the early events in the insulin- signaling cascade follow from this activation event. This establishes a critical role for PTP(s) in the regulation of IRK activity. bpV(phen) could be distinguished from insulin only in its ability to activate ERK1 in HTC-M1030 cells, thus indicating that this event is IRK independent, consistent with our previous hypothesis that bpV(phen) inhibits a PTP involved in the negative regulation of mitogen-activated protein kinases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9415395     DOI: 10.1210/mend.11.13.0041

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  6 in total

Review 1.  Orally active insulin mimics: where do we stand now?

Authors:  M Balasubramanyam; V Mohan
Journal:  J Biosci       Date:  2001-09       Impact factor: 1.826

2.  Downregulation of PTEN at corneal wound sites accelerates wound healing through increased cell migration.

Authors:  Lin Cao; Enrique O Graue-Hernandez; Vu Tran; Brian Reid; Jin Pu; Mark J Mannis; Min Zhao
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-08       Impact factor: 4.799

3.  Association of protein tyrosine phosphatases (PTPs)-1B with c-Met receptor and modulation of corneal epithelial wound healing.

Authors:  Azucena Kakazu; Guru Sharma; Haydee E P Bazan
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-07       Impact factor: 4.799

4.  Small-molecule protein tyrosine phosphatase inhibition as a neuroprotective treatment after spinal cord injury in adult rats.

Authors:  Shojiro Nakashima; Sheila A Arnold; Edward T Mahoney; Srinivas D Sithu; Y Ping Zhang; Stanley E D'Souza; Christopher B Shields; Theo Hagg
Journal:  J Neurosci       Date:  2008-07-16       Impact factor: 6.167

5.  A method to control phosphoinositides and to analyze PTEN function in living cells using voltage sensitive phosphatases.

Authors:  Angeliki Mavrantoni; Veronika Thallmair; Michael G Leitner; Daniela N Schreiber; Dominik Oliver; Christian R Halaszovich
Journal:  Front Pharmacol       Date:  2015-03-31       Impact factor: 5.810

6.  Regulation of colonic apical potassium (BK) channels by cAMP and somatostatin.

Authors:  M D Perry; G I Sandle
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-30       Impact factor: 4.052

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.